source
- Latigo Biotherapeutics plans IPO to fund phase 3 trials of non-opioid pain drug LTG-001Latigo Biotherapeutics announced it is preparing an initial public offering to raise capital for its clinical-stage, non-opioid pain management pipeline. The company highlighted its oral Nav1.8 in…
- Zen Principle Moringa Capsules Recalled Over Possible Salmonella ContaminationRelay Peak Research LLC, operating as Zen Principle Naturals, announced a voluntary recall of its Zen Principle brand Moringa Leaf Powder Capsules. The recall was triggered by a potential contamin…